Citius Pharmaceuticals In...

NASDAQ: CTXR · Real-Time Price · USD
1.33
0.02 (1.53%)
At close: Aug 15, 2025, 3:59 PM
1.33
0.00%
After-hours: Aug 15, 2025, 04:10 PM EDT

Citius Pharmaceuticals Income Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Sep 30, 2024 Sep 30, 2023 Sep 30, 2022 Sep 30, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
209.61K 194.32K 179.68K 164.87K
Gross Profit
-209.61K -194.32K -179.68K -164.87K
Operating Income
-42M -36.73M -33.32M -23.53M
Interest Income
758K 1.18M 251.4K 261.82K
Pretax Income
-38.85M -31.97M -33.06M -23.05M
Net Income
-39.43M -32.54M -33.64M -23.13M
Selling & General & Admin
18.25M 21.91M 15.66M 11.29M
Research & Development
11.91M 14.82M 17.66M 12.24M
Other Expenses
11.84M -0.00 n/a 59.92K
Operating Expenses
42M 36.54M 33.32M 23.53M
Interest Expense
n/a n/a 251.4K 10.84K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
41.99M 36.73M 33.32M 23.53M
Income Tax Expense
576K 576K 576K 70.76K
Shares Outstanding (Basic)
11.59M 9.74M 9.74M 7.24M
Shares Outstanding (Diluted)
11.59M 10.09M 9.74M 7.24M
EPS (Basic)
-5.97 -0.22 -0.23 -0.21
EPS (Diluted)
-5.97 -0.22 -0.23 -0.21
EBITDA
-38.64M -31.77M -32.88M -22.88M
EBIT
-38.85M -31.97M -33.06M -23.04M
Depreciation & Amortization
209.61K 194.32K 179.68K 164.87K